| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |